Mar 16, 2016 Syros Pharmaceuticals to Present Preclinical Data on SY-1425 and CDK7 Inhibitor Program in Blood Cancers at Upcoming AACR Annual Meeting
Mar 3, 2016 Publication in Science Further Validates Importance of Gene Control Research in Yielding New Insights into Diagnosing and Treating Cancer
Dec 5, 2015 Syros Pharmaceuticals Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of First-in-Class Selective CDK7 Inhibitor in Models of Acute Leukemias
Nov 10, 2015 Syros Pharmaceuticals Announces Issuance of U.S. Patents Related to Its Gene Control Drug Discovery and Development Platform
Nov 5, 2015 Syros Pharmaceuticals to Present Preclinical Data on First-in-Class Selective CDK7 Inhibitor Program at American Society of Hematology (ASH) Annual Meeting
Oct 19, 2015 Syros Pharmaceuticals Appoints Industry Leader Marsha H. Fanucci to Its Board of Directors